tyrosine has been researched along with bis(maltolato)oxovanadium(iv) in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duncker, DJ; Gho, BC; Gho, CC; Kazim, S; Liem, DA; Manintveld, OC; Verdouw, PD | 1 |
Brady, MJ; Makinen, MW; Mustafi, D; Ou, H; Yan, L | 1 |
2 other study(ies) available for tyrosine and bis(maltolato)oxovanadium(iv)
Article | Year |
---|---|
The tyrosine phosphatase inhibitor bis(maltolato)oxovanadium attenuates myocardial reperfusion injury by opening ATP-sensitive potassium channels.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Rate; Male; Membrane Proteins; Myocardial Infarction; Myocardial Reperfusion Injury; Potassium Channels; Protein Tyrosine Phosphatases; Pyrones; Rats; Rats, Wistar; Time Factors; Tyrosine; Vanadates | 2004 |
The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Chelating Agents; Enzyme Activation; Glycogen; Glycogen Synthase; Hypoglycemic Agents; Insulin Resistance; Mice; Molecular Structure; Organometallic Compounds; Phosphorylation; Pyrones; Receptor, Insulin; Solutions; Tyrosine; Vanadates | 2005 |